What is red-light therapy and photobiomodulation?
The short version
“Red-light therapy” is a broad consumer label. Photobiomodulation (PBM) is the more precise research term for non-thermal biological responses to light delivered within defined parameters. The terms overlap, but neither term proves that a particular device, dose or health claim works.
A 2015 terminology paper recommended “photobiomodulation therapy” in place of older labels such as low-level laser therapy. The change matters because PBM can use lasers or LEDs, and “low level” is an imprecise description.
What light is being discussed?
A 2024 clinical review describes PBM as commonly using visible red light from 620–700 nanometres (nm) and near-infrared light from 700–1440 nm. Those are broad spectral ranges, not a statement that every wavelength within them has the same effect.
Red light is visible. Near-infrared is beyond the visible-red edge of the spectrum. Consumer panels often combine several nominal wavelengths, but a list of wavelengths alone does not tell you the dose reaching tissue.
Read the wavelength explainer →
What might happen in tissue?
Reviews describe proposed pathways beginning when cellular chromophores absorb photons. Cytochrome c oxidase and light-sensitive ion channels are among the mechanisms discussed, followed by changes in signalling involving ATP, reactive oxygen species, nitric oxide and calcium.
That is a biological model, not a blanket clinical conclusion. A mechanism that is plausible in a cell or animal model does not automatically mean a consumer device improves a specific condition in people.
Dose is more than wavelength
Interpretation depends on the complete protocol: wavelength, optical output, treatment distance, exposure time, illuminated area, frequency and the tissue or condition studied. PBM literature also describes a biphasic dose response—more light is not necessarily better.
This is why PLT will not translate a high irradiance number or a long wavelength list into an automatic “stronger” or “better” ranking. Figures measured at different distances or with different instruments are not directly interchangeable.
How to read health claims
Ask a narrow question: was this outcome studied in people with the same condition, using a comparable protocol and an appropriate control? Laboratory and animal research can help explain a hypothesis. It cannot by itself establish a treatment benefit in humans.
Evidence also varies by application. A result in transplant-associated oral mucositis, for example, does not validate claims about exercise recovery, skin, sleep or every other advertised use.
Red-light products are not a substitute for diagnosis or medical care. Follow device instructions and seek qualified health advice for symptoms, diagnosed conditions, medicines that affect light sensitivity, pregnancy, or uncertainty about eye exposure.
Read the NASA history without the origin myth →
Sources and references
- Juanita J. Anders, Raymond J. Lanzafame, Praveen R. Arany. Low-level light/laser therapy versus photobiomodulation therapy. Photomedicine and Laser Surgery. 2015-04. DOI: 10.1089/pho.2015.9848. PMID: 25844681. Accessed 2026-09-07.
- Michael R. Hamblin. Mechanisms and applications of the anti-inflammatory effects of photobiomodulation. AIMS Biophysics. 2017-05-19. DOI: 10.3934/biophy.2017.3.337. PMID: 28748217. Accessed 2026-09-07.
- Jalal Maghfour et al.. Photobiomodulation CME part I: Overview and mechanism of action. Journal of the American Academy of Dermatology. 2024-11. DOI: 10.1016/j.jaad.2023.10.073. PMID: 38309304. Accessed 2026-09-07.